Rokote Laboratories Finland Oy

This early-stage trial tests two versions of a nasal spray vaccine called COV2, designed to protect against COVID-19. About 20 healthy adults who have already had at least two COVID-19 shots will receive two doses of the nasal vaccine. The study checks for side effects and measur…